Ceritinib, 500 mg

Ceritinib is an established chemical intermediate, identified as a kinase inhibitor. Its molecular formula is C27H31F4N5O3, with a molecular weight of 533.55 g/mol. This compound is known for its role as a selective inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1). It is offered in a pure form, with a purity of 99% and a pack size of 500 mg. Ceritinib has demonstrated efficacy in the treatment of certain types of non-small cell lung cancer (NSCLC) and inflammatory myofibroblastic tumors (IMTs). Additionally, it exhibits potent activity against several other kinases, including c-Met, BCR-ABL, and EGFR.

• CAS Number: 1032900-25-6